Key facts
- Notable investors include Kima Ventures, IncubAlliance, Institut d'Optique Graduate School, Teampact Ventures.
- Unveil has filed 1 Form D with the SEC, most recently Sep 2010 ($200K sold to 6 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Unveil
- ·The full record, as it builds
Funding rounds
No funding rounds for Unveil are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Unveil
Manufacturer of nanoparticle characterization instruments designed for quantitative analysis of nanoscale biological and synthetic particles. The company measures empty, partial, and full capsid ratios, particle concentration, and aggregation in nanoparticles between 20 and 300 nanometers, operates with low sample volumes, requires no labelling, and produces results in minutes, enabling biopharmaceutical manufacturers and research laboratories to monitor production yield, control quality parameters, and standardize nanoparticle characterization workflows.
- Sector
- Healthcare
- HQ
- Verrières-le-Buisson, France
- Founded
- 2024
- Employees
- 5
- Website
- unveil-instruments.com/
- Ownership
- Privately Held (backing)
Unveil doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Unveil shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Unveil in its N-PORT filings yet. We sweep new filings monthly.